Is Nike a Buy After Its Q4 Earnings Beat?

Nike (NKE) reported fourth-quarter fiscal 2025 earnings that surpassed analyst expectations on both sales ($11.1B vs. $10.7B est.) and EPS ($0.14 vs. $0.13 est.), leading to an initial stock rally. However, the underlying financial performance revealed significant headwinds, including a 12% year-over-year sales decline across all major markets and an 86% plunge in net income, attributed to compressed margins and increased marketing spend. Furthermore, the company projects a $1 billion impact from tariffs, underscoring vulnerability to global trade policies and the potential for price increases to dampen demand, leading analysts to advise caution despite the new CEO's turnaround efforts.

Analysis

Despite Nike (NKE) reporting fourth-quarter fiscal 2025 results that surpassed consensus estimates, with sales of $11.1 billion versus a $10.7 billion forecast and EPS of $0.14 versus $0.13, the underlying fundamentals reveal significant deterioration. The headline beat masks a severe 12% year-over-year decline in sales across every major market, indicating broad-based demand weakness. Profitability has been severely impacted, with net income collapsing by 86% due to compressed margins and increased marketing spend. Looking ahead, the company faces a material headwind from tariffs, which management projects will negatively impact the business by approximately $1 billion in the current fiscal year. While the new CEO expresses optimism and plans to mitigate tariff effects through price increases and supply chain adjustments, these measures carry the risk of further dampening consumer demand. The stock's valuation, at over 30 times earnings, appears stretched in the context of plummeting revenue and profitability, suggesting the recent stock price increase may be a reaction to a low-quality earnings beat rather than a fundamental business turnaround.

Key Decisions for Investors

• Investors should look past the short-term headline earnings beat and focus on the deteriorating fundamentals, specifically the 12% year-over-year revenue decline and the 86% collapse in net income.
• Monitor the impact of management's planned price increases on sales volumes, as this will be a key indicator of whether the company can mitigate the $1 billion tariff impact without destroying demand.
• Given the substantial operational risks, declining profitability, and high valuation multiple, consider a cautious or neutral stance, as a 'wait-and-see' approach is prudent until there is tangible evidence of a successful operational turnaround.